Get 20% lifetime commission for referring investors to digrin.com
here.
Avidity Biosciences, Inc. ( RNA) - Stock Earnings
Stock symbol RNA is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker RNA was renamed to
RNAM
effective 2026-02-26.
RNA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
RNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -157.3 million USD | 3.8 million USD |
| 2025Q3 | -174.4 million USD | 12.5 million USD |
| 2025Q4 | -237.1 million USD | 860000 USD |
RNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -212.2 million USD | 9.6 million USD |
| 2024 | -322.3 million USD | 10.9 million USD |
| 2025 | -684.6 million USD | 18.8 million USD |
RNA
Price: $13.21
52 week price:
Earnings Per Share: -4.48 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 810900
Market Capitalization: 229.9 million